long consolidation and parallel channel breakout with volume
ZYDUSLIFE
Time frame- DAILY
*Resistance - 200DMA or 380 once closing above 380 than upside till 436 is possible.
*Support - 100 DMA
*Short term to medium term
*Reason- long consolidation, and parallel channel breakout with volume, taken support on 100DMA
Disclaimer:- I am not SEBI registered analyst. Only for information and education purpose. Please consult your adviser before investing.
#technicalanalysis #technicalanalyst #swingtrading #swingtrader #fundamentalanalysis #bullish #chartoftheweek #trading #tradingstrategy #stockmarket #stockmarketindia #stocks #stockmarketnews #stockstowatch #stockstobuy #stockoptions #longterminvestment #investment #investmentopportunities
#derivatives #derivativestrading #index #indexinvesting #optiontrading #chartanalysis #trader #tradingsignals #tradingview #education #breakout #pattern #information #investing #consolidation #consult #supporting #volume #long #ZYDUSLIFE #PHARMA
Time frame- DAILY
*Resistance - 200DMA or 380 once closing above 380 than upside till 436 is possible.
*Support - 100 DMA
*Short term to medium term
*Reason- long consolidation, and parallel channel breakout with volume, taken support on 100DMA
Disclaimer:- I am not SEBI registered analyst. Only for information and education purpose. Please consult your adviser before investing.
#technicalanalysis #technicalanalyst #swingtrading #swingtrader #fundamentalanalysis #bullish #chartoftheweek #trading #tradingstrategy #stockmarket #stockmarketindia #stocks #stockmarketnews #stockstowatch #stockstobuy #stockoptions #longterminvestment #investment #investmentopportunities
#derivatives #derivativestrading #index #indexinvesting #optiontrading #chartanalysis #trader #tradingsignals #tradingview #education #breakout #pattern #information #investing #consolidation #consult #supporting #volume #long #ZYDUSLIFE #PHARMA
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.